I don't think people realize what little it is going to

New Post Public Reply Private Reply Replies (0) Message Board
MaxShockeR

I don't think people realize what little it is going to take to get a rise in the share price...

Currently there are 2.137 billion shares outstanding (since last filings).

1 billion of those shares were purchased and are being held by Victory Partners, which means we will likely never see those hit  the market.

$2 million on the books gets a share price of .001 (where we are now). The Indy Car assets are well over this amount.

$20 million gets a share price of .01. The company has spent at least $5 million on filings, attorneys, ticker changes, travel, advertising, sponsorships, and various other company promotions.

$200 million gets a share price of .10.

All this is based on if there are still 2.137 billion shares out there. If this thing had that many shares out there, it wouldn't  of gotten out of trips, IMO. It's trading on a few hundred dollars
at a time. The walls on the ask always move when there is a  significant purchase.

We all know the rumors of the company buying back shares. Well, it is not far fetched at all. If they reduce the O/S by half, we can easily double the share prices. Such as:

$2 million on the books would put the price at .002.
$20 million @ .02.
$200 million @ .20.

I'd say it's very easy to obtain these prices if the share buy back is true, and I would assume this company has assets and money on hand well over $100 million. The distillery alone must be worth several million, plus the Indy cars, etc. etc.

Yea, it's no Diageo, but guess what... Cuervo has nothing on Tequila D.

Oh, and the O/S is technically reduced by half since Victory would never sell a billion shares into the market. It would destroy their investment in Emperial. So if the company further bought up the float to say, 800 million, prices go even higher.

(posted by Seccotech)

$TEMN

Top Shelf Brands Holdings Corp. (DKTS) Stock Research Links

DKTS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Merck & Co., Inc. Investors Urged to Take Action Now

Updated Category News Views 131

Important Notice for Merck & Co., Inc. Investors Investors in Merck & Co., Inc. (MRK) are being encouraged to seek legal counsel as we approach a significant deadline related to a securities class action lawsuit. This timeline marks an important opportunity for purchasers of Merck's securities made between February 3, 2022, and February 3, 2025, to secure representation...

Continue Reading
Justice-Impacted Individuals Gaining Access to Education

Updated Category News Views 116

Expanding Opportunities for Justice-Impacted Individuals In a significant initiative aimed at improving the lives of justice-impacted individuals, multiple states are coming together to enhance educational and workforce pathways. This collaborative effort is focused on providing necessary resources and opportunities for individuals who have faced incarceration, aiming to...

Continue Reading
Celebrating Excellence: 2025 Lifetime Achievement Award Recipients

Updated Category News Views 123

Honoring Peter Murray and SawTeen See at the CTBUH 2025 Awards The Council on Tall Buildings and Urban Habitat (CTBUH) has recognized two remarkable figures in the field of architecture and structural engineering for their essential contributions to urban design. Peter Murray, co-founder of New London Architecture, and SawTeen See, a prominent structural engineer, are the...

Continue Reading
Northern Oil and Gas Expands Horizons with Acquisition Talks

Updated Category News Views 145

Northern Oil and Gas Options for Strategic Growth Northern Oil and Gas is actively pursuing acquisition opportunities, specifically targeting Granite Ridge Resources. Based in Minneapolis, this ambitious company has shown intent to enhance its portfolio by considering Granite Ridge, a relatively smaller player in the oil industry, skilled in extracting resources from...

Continue Reading
Invivyd Announces Insights into VYD2311's Clinical Journey

Updated Category News Views 176

Invivyd Hosts Webcast to Discuss the REVOLUTION Program Invivyd, Inc. (Nasdaq: IVVD) will present a live webcast detailing its innovative REVOLUTION clinical program. This event, aimed at both investors and the public, will showcase the company’s promising monoclonal antibody, VYD2311, which serves as a vaccine alternative for COVID-19 prevention. The Overview of...

Continue Reading